Blackstone Life Sciences VI L.P. is a private equity fund based in New York, New York. According to its most recent Form D, filed Apr 2, 2026, it has sold $6,300,000,000 of interests to 119 investors since its first sale in Dec 2024. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Omar Rehman; Victoria Portnoy; Christopher Striano.
- Total raised
- $6,300,000,000Cumulative sales reported on Form D
- Investors
- 119
- First sale
- Dec 18, 2024
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Omar Rehman; Victoria Portnoy; Christopher Striano
- Latest Form D
- Apr 2, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Blackstone Life Sciences VI L.P.
What is the minimum investment for Blackstone Life Sciences VI L.P.?
Blackstone Life Sciences VI L.P.'s latest Form D, filed Apr 2, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Blackstone Life Sciences VI L.P.?
Blackstone Life Sciences VI L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Blackstone Life Sciences VI L.P. raised?
Blackstone Life Sciences VI L.P. reports $6,300,000,000 sold from 119 investors on its Form D filed Apr 2, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Blackstone Life Sciences VI L.P. based?
Blackstone Life Sciences VI L.P. is based in New York, New York.
When did Blackstone Life Sciences VI L.P. launch?
Blackstone Life Sciences VI L.P. reports its first sale in Dec 2024.
Size compared with every private equity fund
Raised more than 99% of the 3,770 private equity funds based in New York, and more than 99% of all 9,142 that report sales.
Other funds with the same team
- Blackstone Capital Partners IX (LUX) SCSp$20B
- Blackstone Capital Partners IX L.P.$20B
- Blackstone Capital Partners Asia III (LUX) SCSp$8.0B
- Blackstone Life Sciences VI (LUX) SCSp$6.3B
- Blackstone Growth II - B L.P.$4.5B
- Blackstone Growth II L.P.$4.2B
- Blackstone Infrastructure Partners Europe F (CYM) L.P.$1.3B
- Blackstone Energy Transition Partners IV L.P.$1.0B